Eating disorders (EDs), including anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED), are serious psychiatric disorders that often first manifest in adolescence and are associated with dangerous medical complications, high rates of comorbid psychopathology, and significant psychosocial impairment (American Psychiatric Association, 2013). EDs affect approximately 1% to 3% of individuals and tend to be more common in girls and women, with only around 10% occurring in boys and men (Klein & Walsh, 2003), although improvements in the characterization of EDs in male individuals suggest this percentage may be much higher (Nagata et al., 2020). AN has the highest mortality rate of all psychiatric disorders and is the third most common chronic illness in female adolescents. AN is characterized by the restriction of energy intake leading to significantly low body weight, intense fear of gaining weight, and a marked disturbance in the experience of one' s weight and shape (American Psychiatric Association, 2013). The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) includes two subtypes of AN: the binge-eating/ purging subtype (AN-BP), defined by regular binge eating and/or purging, and the restricting subtype (AN-R), defined by the absence of binge-eating or purging symptoms. BN is characterized by recurrent cycles of binge eating, defined as the consumption of a large amount of food in a short time period that are often combined with a sense of loss of control over eating, and compensatory behavior (e.g., self-induced vomiting), as well as periods of dietary restraint, but individuals are not low weight (American Psychiatric Association, 2013). Individuals with BED, roughly 40% of whom are obese, engage in recurrent binge eating without compensatory behaviors (American Psychiatric Association, 2013).The etiology of EDs is likely complex and poorly understood, which has hindered development of effective treatments. Less than 50% of treatment seekers with AN, BN, or BED achieve behavioral and/ or psychological remission (Keel et al., 1999;van den Berg et al., 2019), resulting in a chronic relapsing and remitting course for many. Advances in our understanding of the pathophysiology of EDs are beginning to offer new targets of treatment that may help to improve treatment outcome. This chapter focuses primarily on neuropsychological and brain alterations in AN, BN, and BED. Due to limited studies of neurocognitive function, feeding disorders (e.g., pica, avoidant/restrictive food intake disorder, rumination disorder) are not discussed.
WHAT THE FIELD KNOWSEDs are increasingly seen as neurobiologically based disorders, like all psychiatric conditions. This chapter reviews the currently accepted neuropsychological science supporting this notion.